文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

补肾活血汤通过调节肠道微生物群和代谢物以及 p38 丝裂原活化蛋白激酶/p65 核因子 κB/水通道蛋白 4 信号通路延缓慢性心力衰竭大鼠心室重构。

Kidney-tonifying blood-activating decoction delays ventricular remodeling in rats with chronic heart failure by regulating gut microbiota and metabolites and p38 mitogen-activated protein kinase/p65 nuclear factor kappa-B/aquaporin-4 signaling pathway.

机构信息

Liaoning University of Traditional Chinese Medicine,Shenyang,Liaoning 110847,China.

Jilin Hospital of Integrated Traditional Chinese and Western Medicine,Jilin,Jilin 132000,China.

出版信息

J Ethnopharmacol. 2024 Aug 10;330:118110. doi: 10.1016/j.jep.2024.118110. Epub 2024 Apr 3.


DOI:10.1016/j.jep.2024.118110
PMID:38580189
Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Myocardial infarction has likely contributed to the increased prevalence of heart failure(HF).As a result of ventricular remodeling and reduced cardiac function, colonic blood flow decreases, causing mucosal ischemia and hypoxia of the villous structure of the intestinal wall.This damage in gut barrier function increases bowel wall permeability, leading to fluid metabolism disorder,gut microbial dysbiosis, increased gut bacteria translocation into the circulatory system and increased circulating endotoxins, thus promoting a typical inflammatory state.Traditional Chinese Medicine plays a key role in the prevention and treatment of HF.Kidney-tonifying Blood-activating(KTBA) decoction has been proved for clinical treatment of chronic HF.However,the mechanism of KTBA decoction on chronic HF is still unclear. AIMS OF THE STUDY: The effect of KTBA decoction on gut microbiota and metabolites and p38MAPK/p65NF-κB/AQP4 signaling in rat colon was studied to investigate the mechanism that KTBA decoction delays ventricular remodeling and regulates water metabolism disorder in rats with HF after myocardial infarction based on the theory of "Kidney Storing Essence and Conducting Water". MATERIAL AND METHODS: In vivo,a rat model of HF after myocardial infarction was prepared by ligating the left anterior descending coronary artery combined with exhaustive swimming and starvation.The successful modeling rats were randomly divided into five groups:model group, tolvaptan group(gavaged 1.35mg/(kg•D) tolvaptan),KTBA decoction group(gavaged 15.75g/(kg•D) of KTBA decoction),KTBA decoction combined with SB203580(p38MAPK inhibitor) group(gavaged 15.75g/(kg•D) of KTBA decoction and intraperitoneally injected 1.5mg/(kg•D) of SB203580),and KTBA decoction combined with PDTC(p65NF-kB inhibitor) group(gavaged 15.75g/(kg•D) of KTBA decoction and intraperitoneally injected 120mg/(kg•D) of PDTC).The sham-operation group and model group were gavaged equal volume of normal saline.After 4 weeks of intervention with KTBA decoction,the effect of KTBA decoction on the cardiac structure and function of chronic HF model rats was observed by ultrasonic cardiogram.General state and cardiac index in rats were evaluated.Enzyme linked immunosorbent assay(ELISA) was used to measure N-terminal pro-brain natriuretic peptide (NT-proBNP) concentration in rat serum.Hematoxylin and eosin(H&E) staining,and transmission electron microscope(TEM) were used to observe the morphology and ultrastructure of myocardial and colonic tissue,and myocardial fibrosis was measured by Masson's staining.Cardiac E-cadherin level was detected by Western blot.The mRNA expression and protein expression levels of p38MAPK,I-κBα, p65NF-κB,AQP4,Occludin and ZO-1 in colonic tissue were detected by reverse transcription-quantitative real-time polymerase chain reaction(RT-qPCR) and immunohistochemistry. Protein expression of p38MAPK, p-p38MAPK,I-κBα,p-I-κBα,p65NF-κB, p-p65NF-κB,AQP4,Occludin and ZO-1 in rat colon was detected using Western blot.Colonic microbiota and serum metabolites were respectively analyzed by amplicon sequencing and liquid chromatography-mass spectrometry.In vitro, CCD-841CoN cell was placed in the ischemic solution under hypoxic conditions (94%N,5%CO,and 1%O) in a 37 °C incubator to establish an ischemia and hypoxia model.The CCD-841CoN cells were divided into 7 groups, namely blank group and model group with normal rat serum plus control siRNA, tolvaptan group with rat serum containing tolvaptan plus control siRNA, KTBA group with rat serum containing KTBA plus control siRNA, KTBA plus p38MAPK siRNA group, KTBA plus p65NF-κB siRNA group,and KTBA plus AQP4siRNA group.After 24h and 48h of intervention with KTBA decoction,RT-qPCR,immunofluorescence and Western blot was used to detect the mRNA expression and protein expression levels of p38MAPK,I-κBα,p65NF-κB,AQP4, Occludin and ZO-1 in CCD-841CoN cells. RESULTS: Compared with the model, KTBA decoction improved the general state, decraesed the serum NT-proBNP level,HW/BW ratio, LVIDd and LVIDs, increased E-cadherin level,EF and FS,reduced number of collagen fibers deposited in the myocardial interstitium,and recovered irregular arrangement of myofibril and swollen or vacuolated mitochondria with broken crista in myocardium.Moreover, KTBA decoction inhibited the expression of p38MAPK,I-κBα,and p65NF-κB and upregulated AQP4, Occludin and ZO-1 in colon tissues and CCD-841CoN cells.Additionally,p38siRNA or SB203580, p65siRNA or PDTC, and AQP4siRNA partially weakened the protective effects of KTBA in vitro and vivo.Notably,The LEfSe analysis results showed that there were six gut biomaker bacteria in model group, including Allobaculum, Bacillales,Turicibacter, Turicibacterales,Turicibacteraceae,and Bacilli. Besides, three gut biomaker bacteria containing Deltaproteobacteria, Desulfovibrionaceae,and Desulfovibrionales were enriched by KTBA treatment in chronic HF model.There were five differential metabolites, including L-Leucine,Pelargonic acid, Capsidiol,beta-Carotene,and L- Erythrulose, which can be regulated back in the same changed metabolic routes by the intervention of KTBA.L-Leucine had the positive correlation with Bacillales, Turicibacterales,Turicibacteraceae,and Turicibacter.L-Leucine significantly impacts Protein digestion and absorption, Mineral absorption,and Central carbon metabolism in cancer regulated by KTBA, which is involved in the expression of MAPK and tight junction in intestinal epithelial cells. CONCLUSIONS: KTBA decoction manipulates the expression of several key proteins in the p38MAPK/p65NF-κB/AQP4 signaling pathway, modulates gut microbiota and metabolites toward a more favorable profile, improves gut barrier function, delays cardiomyocyte hypertrophy and fibrosis,and improves cardiac function.

摘要

ETHNOPHARMACOLOGICAL RELEVANCE: 心肌梗死可能导致心力衰竭(HF)的患病率增加。由于心室重构和心功能降低,结肠血流减少,导致肠壁绒毛结构的黏膜缺血和缺氧。这种肠道屏障功能的损伤增加了肠壁通透性,导致液体代谢紊乱、肠道微生物失调、肠道细菌向循环系统的转移增加和循环内毒素增加,从而促进典型的炎症状态。中药在 HF 的防治中发挥着关键作用。补肾活血(KTBA)汤已被证明可用于慢性 HF 的临床治疗。然而,KTBA 汤治疗慢性 HF 的机制仍不清楚。

AIMS OF THE STUDY: 本研究旨在探讨 KTBA 汤对大鼠结肠中肠道微生物群和代谢物以及 p38MAPK/p65NF-κB/AQP4 信号通路的影响,研究 KTBA 汤通过“肾藏精,主水”理论延迟心肌梗死后 HF 大鼠心室重构和调节水代谢紊乱的机制。

MATERIAL AND METHODS: 在体内,通过结扎左前降支冠状动脉结合耗尽游泳和饥饿的方法制备心肌梗死后 HF 大鼠模型。成功建模的大鼠随机分为五组:模型组、托伐普坦组(灌胃 1.35mg/(kg•D)托伐普坦)、KTBA 汤组(灌胃 15.75g/(kg•D)KTBA 汤)、KTBA 汤联合 SB203580(p38MAPK 抑制剂)组(灌胃 15.75g/(kg•D)KTBA 汤和腹腔注射 1.5mg/(kg•D)SB203580)和 KTBA 汤联合 PDTC(p65NF-κB 抑制剂)组(灌胃 15.75g/(kg•D)KTBA 汤和腹腔注射 120mg/(kg•D)PDTC)。假手术组和模型组灌胃等体积生理盐水。干预 KTBA 汤 4 周后,通过超声心动图观察慢性 HF 模型大鼠的心脏结构和功能。评估大鼠的一般状态和心功能指数。采用酶联免疫吸附试验(ELISA)法测定大鼠血清中 N-端脑钠肽前体(NT-proBNP)的浓度。苏木精-伊红(H&E)染色和透射电镜(TEM)观察心肌和结肠组织的形态和超微结构,采用 Masson 染色测量心肌纤维化程度。采用 Western blot 检测心脏 E-钙黏蛋白水平。采用逆转录定量实时聚合酶链反应(RT-qPCR)和免疫组化法检测结肠组织中 p38MAPK、I-κBα、p65NF-κB、AQP4、Occludin 和 ZO-1 的 mRNA 表达和蛋白表达水平。采用 Western blot 检测大鼠结肠中 p38MAPK、p-p38MAPK、I-κBα、p-I-κBα、p65NF-κB、p-p65NF-κB、AQP4、Occludin 和 ZO-1 的蛋白表达。采用扩增子测序和液相色谱-质谱联用技术分别分析结肠微生物群和血清代谢物。体外,将 CCD-841CoN 细胞置于缺氧条件下(94%N、5%CO 和 1%O)的缺血溶液中(37°C 孵育箱)建立缺血缺氧模型。将 CCD-841CoN 细胞分为 7 组,即空白组和用含正常大鼠血清的对照 siRNA 处理的模型组、用含托伐普坦的大鼠血清加对照 siRNA 处理的托伐普坦组、用含 KTBA 的大鼠血清加对照 siRNA 处理的 KTBA 组、用含 KTBA 的大鼠血清加 p38MAPK siRNA 处理的 KTBA 加 p38MAPK siRNA 组、用含 KTBA 的大鼠血清加 p65NF-κB siRNA 处理的 KTBA 加 p65NF-κB siRNA 组和用含 KTBA 的大鼠血清加 AQP4siRNA 处理的 KTBA 加 AQP4siRNA 组。干预 KTBA 汤 24h 和 48h 后,采用 RT-qPCR、免疫荧光和 Western blot 法检测 CCD-841CoN 细胞中 p38MAPK、I-κBα、p65NF-κB、AQP4、Occludin 和 ZO-1 的 mRNA 表达和蛋白表达水平。

RESULTS: 与模型组相比,KTBA 汤改善了大鼠的一般状态,降低了血清 NT-proBNP 水平、HW/BW 比值、LVIDd 和 LVIDs,增加了 E-钙黏蛋白水平,提高了 EF 和 FS,减少了心肌间质沉积的胶原纤维数量,恢复了心肌不规则排列的肌原纤维和肿胀或空泡化的线粒体,嵴断裂。此外,KTBA 汤抑制了 p38MAPK、I-κBα 和 p65NF-κB 的表达,并上调了结肠组织和 CCD-841CoN 细胞中 AQP4、Occludin 和 ZO-1 的表达。此外,p38siRNA 或 SB203580、p65siRNA 或 PDTC 和 AQP4siRNA 部分削弱了 KTBA 汤在体内和体外的保护作用。值得注意的是,LEfSe 分析结果显示,模型组中有 6 种肠道生物标志物细菌,包括 Allobaculum、Bacillales、Turicibacter、Turicibacterales、Turicibacteraceae 和 Bacilli。此外,通过 KTBA 处理,慢性 HF 模型中还富集了 3 种肠道生物标志物细菌,包括 Deltaproteobacteria、Desulfovibrionaceae 和 Desulfovibrionales。此外,还发现了 5 种差异代谢物,包括 L-Leucine、Pelargonic acid、Capsidiol、beta-Carotene 和 L- Erythrulose,它们可以通过 KTBA 的干预在相同的变化代谢途径中恢复。L-Leucine 与 Bacillales、Turicibacterales、Turicibacteraceae 和 Turicibacter 呈正相关。L-Leucine 显著影响 KTBA 调节的癌症中 MAPK 和紧密连接的蛋白表达,涉及肠道上皮细胞中肠道微生物群和代谢物的改变。

CONCLUSIONS: KTBA 汤通过调节 p38MAPK/p65NF-κB/AQP4 信号通路中的几个关键蛋白,调节肠道微生物群和代谢物向更有利的方向发展,改善肠道屏障功能,延缓心肌细胞肥大和纤维化,改善心功能。

相似文献

[1]
Kidney-tonifying blood-activating decoction delays ventricular remodeling in rats with chronic heart failure by regulating gut microbiota and metabolites and p38 mitogen-activated protein kinase/p65 nuclear factor kappa-B/aquaporin-4 signaling pathway.

J Ethnopharmacol. 2024-8-10

[2]
Linggui Zhugan decoction delays ventricular remodeling in rats with chronic heart failure after myocardial infarction through the Wnt/β-catenin signaling pathway.

Phytomedicine. 2023-11

[3]
Shenling Baizhu Decoction treats ulcerative colitis of spleen-deficiency and dampness obstruction types by targeting 'gut microbiota and galactose metabolism-bone marrow' axis.

J Ethnopharmacol. 2024-12-5

[4]
Regulatory effects of the p38 mitogen-activated protein kinase-myosin light chain kinase pathway on the intestinal epithelial mechanical barrier and the mechanism of modified Pulsatilla decoction in the treatment of ulcerative colitis.

J Tradit Chin Med. 2024-10

[5]
Chang-Kang-Fang alleviates diarrhea predominant irritable bowel syndrome (IBS-D) through inhibiting TLR4/NF-κB/NLRP3 pathway.

J Ethnopharmacol. 2024-8-10

[6]
[Shenfu Injection regulates macrophage polarization via TLR4/NF-κB pathway to reduce inflammation in chronic heart failure].

Zhongguo Zhong Yao Za Zhi. 2024-7

[7]
Panax Notoginseng Saponins Inhibits Ventricular Remodeling after Myocardial Infarction in Rats Through Regulating ATF3/MAP2K3/p38 MAPK and NF κ B Pathway.

Chin J Integr Med. 2020-12

[8]
YiQiFuMai Powder Injection attenuates coronary artery ligation-induced myocardial remodeling and heart failure through modulating MAPKs signaling pathway.

J Ethnopharmacol. 2017-2-22

[9]
Effects of Buyang Huanwu Decoction on Intestinal Barrier, Intestinal Flora, and Trimethylamine Oxide in Rats with Heart Failure.

Chin J Integr Med. 2023-2

[10]
Gut microbiota modulation and anti-inflammatory properties of Xuanbai Chengqi decoction in septic rats.

J Ethnopharmacol. 2021-3-1

引用本文的文献

[1]
Effects of swimming training on cecum microorganisms and metabolites in rats with high fat diet.

Front Mol Biosci. 2025-8-8

[2]
The Effect of the AQP1 Gene Knockout on the Diversity, Composition and Function of Gut Microbiota in Mice with Heart Failure.

Biology (Basel). 2025-7-4

[3]
Uncovering the molecular mechanisms of tonifying kidney and activating blood Decoction against myocardial fibrosis using network Pharmacology and experimental validation.

Sci Rep. 2025-5-29

[4]
The Role of the Gut Microbiota in Heart Failure: Pathophysiological Insights and Future Perspectives.

Medicina (Kaunas). 2025-4-14

[5]
Bunge root in the treatment of myocardial fibrosis: research progress and challenges.

Front Pharmacol. 2025-3-31

[6]
The gut microbiota-inflammation-HFpEF axis: deciphering the role of gut microbiota dysregulation in the pathogenesis and management of HFpEF.

Front Cell Infect Microbiol. 2025-3-13

[7]
The Role of the MAPK Signaling Pathway in Cardiovascular Disease: Pathophysiological Mechanisms and Clinical Therapy.

Int J Mol Sci. 2025-3-16

[8]
New insights into the intestinal barrier through "gut-organ" axes and a glimpse of the microgravity's effects on intestinal barrier.

Front Physiol. 2024-10-10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索